oxaprozin

Generic: oxaprozin

Labeler: dr. reddy's laboratories limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxaprozin
Generic Name oxaprozin
Labeler dr. reddy's laboratories limited
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

oxaprozin 600 mg/1

Manufacturer
Dr. Reddy's Laboratories Limited

Identifiers & Regulatory

Product NDC 55111-170
Product ID 55111-170_0de300a2-2952-29fb-80ad-7b2cab86e101
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075855
Listing Expiration 2026-12-31
Marketing Start 2001-01-31

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55111170
Hyphenated Format 55111-170

Supplemental Identifiers

RxCUI
312132
UPC
0355111170013
UNII
MHJ80W9LRB
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxaprozin (source: ndc)
Generic Name oxaprozin (source: ndc)
Application Number ANDA075855 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (55111-170-01)
  • 500 TABLET, FILM COATED in 1 BOTTLE (55111-170-05)
source: ndc

Packages (2)

Ingredients (1)

oxaprozin (600 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0de300a2-2952-29fb-80ad-7b2cab86e101", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0355111170013"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["da457b34-ca08-60df-045b-1ae80d2f7e71"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (55111-170-01)", "package_ndc": "55111-170-01", "marketing_start_date": "20010131"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (55111-170-05)", "package_ndc": "55111-170-05", "marketing_start_date": "20010131"}], "brand_name": "Oxaprozin", "product_id": "55111-170_0de300a2-2952-29fb-80ad-7b2cab86e101", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "55111-170", "generic_name": "Oxaprozin", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA075855", "marketing_category": "ANDA", "marketing_start_date": "20010131", "listing_expiration_date": "20261231"}